Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | TXNRD1 | Q16881 | 6/20 | 0.77 |
| ▸ | TXNRD3 | Q86VQ6 | 6/20 | 0.77 |
| ▸ | TXNRD2 | Q9NNW7 | 6/20 | 0.77 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alfadex SCHEMBL21134960 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL25455463 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL24109285 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL20533920 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL25455531 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL23188277 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL24109286 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL25455476 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL23188251 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL20998969 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8435966-B2 | Associations of xanthogenates and cyclodextrins, and their use | BIOSPHINGS AG (DE) | 2013-05-07 | — | — | US | claimed |
| US-20100240606-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BIOSPHINGS AG (DE) | 2010-09-23 | — | — | US | claimed |
| EP-2001840-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BioSphings AG (DE) | 2008-12-17 | — | — | EP | claimed |
| WO-2007112828-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BIOSPHINGS AG (DE) | 2007-10-11 | — | — | WO | claimed |
| CN-122056893-A | Fritillary bulb octyl for inhibiting gastric cancer, application and composition thereof | 吉林大学 | 2026-05-19 | — | — | CN | disclosed |
| US-12610957-B2 | Compositions and methods of controlling pests | PERTINENT ECO-SOLUTIONS INC. (US) | 2026-04-28 | — | — | US | disclosed |
| EP-4687838-A2 | UNIT DOSAGE COMPOSITION COMPRISING MIDAZOLAM | B. Braun Melsungen AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| US-20260035565-A1 | COMPOSITION COMPRISING A POLYKETIDE PIGMENT | GIVAUDAN SA (CH) | 2026-02-05 | — | — | US | disclosed |
| US-12495820-B2 | Sweetening and taste-masking compositions, products and uses thereof | HealthTech Bio Actives, S.L.U. (ES) | 2025-12-16 | — | — | US | disclosed |
| EP-4656660-A1 | ALFA-, BETA-, AND GAMMA- CYCLODEXTRIN DERIVATIVES DECORATED WITH (2-MERCAPTOETHYL)PHOSPHONIC ACID BRANCHES, SYNTHESIS AND APPLICATIONS | Universidad de Almeria (ES) | 2025-12-03 | — | — | EP | disclosed |
| US-20250359566-A1 | TREATMENTS, METHODS, AND KITS TO PROTECT AGRICULTURAL PRODUCTS FROM WILDFIRE SMOKE | COMESTAAG LLC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4653002-A2 | ORAL TERPENE CYCLODEXTRIN INCLUSION COMPLEX VEHICLES | Czap Research And Development, LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20080132543-A1 | Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists | ALLERGAN, INC. | 2008-06-05 | — | — | US | disclosed |
| US-20080044539-A1 | ASTRINGENCY-COMPENSATED POLYPHENOLIC ANTIOXIDANT-CONTAINING COMESTIBLE COMPOSITION | PERLMAN DANIEL | 2008-02-21 | — | — | US | disclosed |
| WO-2007131106-A2 | ASTRINGENCY-COMPENSATED POLYPHENOLIC ANTIOXIDANT-CONTAINING COMESTIBLE COMPOSITION | SILVER PALATE KITCHENS, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007112828-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | BIOSPHINGS AG (DE) | 2007-10-11 | — | — | WO | disclosed |
| WO-2007064664-A2 | PROSTAGLANDIN EP4 AGONISTS FOR THE TREATMENT OF GASTRIC CONDITIONS | ALLERGAN, INC. (US) | 2007-06-07 | — | — | WO | disclosed |
| US-20070123568-A1 | Therapeutic methods using prostaglandin EP4 agonist components | ALLERGAN, INC. (US) | 2007-05-31 | — | — | US | disclosed |
| US-20070123569-A1 | THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS | ALLERGAN, INC. (US) | 2007-05-31 | — | — | US | disclosed |
| US-20070123569-A1 | THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS | ALLERGAN, INC. (US) | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132543-A1 | Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists | PTGER4, PTGER1, PTGER3 | ALDH1A1 1498/4885TSHR 1581/4885LMNA 2175/4885 |
| US-12610957-B2 | Compositions and methods of controlling pests | DGAT2, DGAT1, DAGLB | ALDH1A1 2856/4885TSHR 3322/4885LMNA 611/4885 |
| US-20070123568-A1 | Therapeutic methods using prostaglandin EP4 agonist components | PTGER4, PTGER1, PTGER3 | ALDH1A1 1047/4885TSHR 1574/4885LMNA 2001/4885 |
| US-20100240606-A1 | ASSOCIATIONS OF XANTHOGENATES AND CYCLODEXTRINS, AND THEIR USE | HLA-DRB1, CXCR3, ANTXR2 | ALDH1A1 4475/4885TSHR 2243/4885LMNA 2992/4885 |
| US-20070123569-A1 | THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS | PTGER4, PTGER1, PTGER3 | ALDH1A1 1121/4885TSHR 803/4885LMNA 2941/4885 |
| US-20260035565-A1 | COMPOSITION COMPRISING A POLYKETIDE PIGMENT | CROCC, NISCH, HBG1 | ALDH1A1 1717/4885TSHR 3711/4885LMNA 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.